BioStem Technologies Launches American Amnion
BioStem Technologies, Inc. (OTC: BSEM), based in Pompano Beach, has stepped into the spotlight by introducing its innovative American Amnion product line. This significant development was unveiled at a prominent medical conference dedicated to limb salvage and wound care, making waves in the MedTech industry and setting a new standard for advanced wound treatment solutions.
Understanding American Amnion
American Amnion AC is an advanced human connective tissue allograft. This allograft features a full thickness dehydrated human amnion and chorion membrane (DHACM) with the essential intermediate layer. Meanwhile, the standard American Amnion is derived solely from dehydrated human amnion membrane (DHAM). Both formulations serve as protective coverings for patients experiencing acute or chronic wounds, showcasing BioStem's commitment to innovation in healthcare.
Revolutionary BioRetain Technology
At the heart of BioStem's allografts is the proprietary BioRetain technology, which ensures that the native structural and molecular composition of the tissue is preserved to an optimal level. Clinical studies have emphasized the superior performance of allografts prepared using this method. In a notable multi-center randomized controlled trial published in a scientific journal, findings demonstrated a substantial increase in wound closure rates among patients treated with BioRetain-preserved tissue compared to those receiving standard treatment.
Clinical Validation and Success Stories
A comparative study published in another healthcare report highlighted how BioStem's DHACM outperformed traditional competitors. This study illustrated a less time-consuming healing process, demonstrating a remarkable 14% reduction in the time required for wound closure and a significant decrease in the number of applications needed to achieve closure. Such compelling evidence underscores BioStem's innovative approach and commitment to enhancing patient outcomes.
Advancing Care for Veterans
Jason Matuszewski, the CEO and Chairman of BioStem Technologies, expressed the company's dedication to serving veterans, who are often affected by chronic wounds. He noted a 50% increase in the use of placental products within the Veterans Affairs system over the past five years. By launching American Amnion, BioStem is not only providing effective solutions for wound care but also enhancing the quality of life for veterans and aiding healthcare providers in delivering more effective care.
Community Engagement and Support Programs
In addition to their commercial aspirations, BioStem Technologies is actively involved in community initiatives that support veterans. The company has partnered with the Florida Panthers to sponsor the 'Heroes Among Us' program. This program serves to publicly acknowledge the sacrifices of U.S. military veterans before every home game, providing a platform for honoring their contributions.
Experience American Amnion at the Conference
Attendees at the Desert Foot Conference can experience American Amnion in various engaging formats. There will be hands-on workshops and presentations showcasing the science behind the amnion technology aimed at optimizing preservation techniques. This engagement not only informs attendees but also encourages collaboration and knowledge sharing among healthcare professionals.
About BioStem Technologies, Inc.
As a pioneering innovator in regenerative therapies, BioStem Technologies is dedicated to developing and commercializing allografts. The company's manufacturing processes incorporate cutting-edge research in regenerative medicine, emphasizing the preservation of growth factors and tissue integrity. Their commitment to quality is reflected in their adherence to Good Tissue Practices and Good Manufacturing Processes, confirmed by accreditations from reputable organizations.
Stay Connected with BioStem
To keep up with the latest advancements from BioStem Technologies, interested individuals can sign up for the company’s distribution list on their official website. Additionally, following them on social media platforms allows everyone to stay informed about future innovations and community engagement efforts.
Frequently Asked Questions
What is American Amnion?
American Amnion is a new product line offered by BioStem Technologies, specializing in placental-derived biologics for wound care, designed to enhance healing and patient outcomes.
How does BioRetain technology improve wound care?
BioRetain technology preserves the natural structural and molecular properties of the tissue, leading to better clinical outcomes and faster wound closure rates compared to traditional treatments.
Why is this product important for veterans?
Veterans often face chronic, non-healing wounds, making advanced treatment options like American Amnion vital for improving their quality of life and healing processes.
Where can I learn more about BioStem Technologies?
More information can be found directly on BioStem Technologies’ official website, where they share their product offerings and advancements in regenerative medicine.
How can I stay updated on BioStem's developments?
Interested individuals can join BioStem's email distribution list and follow them on various social media platforms to receive the latest news and updates.
